Dennis M. Lanfear, President & CEO at Coherus BioSciences, Inc. (CHRS), sold 25,000 shares at $18.56 ($464K) on 2019-11-21, disclosed to the SEC on 2019-11-25.
Open-market sale of $464k CHRS by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.56 | 12,500 | $232K | 50.0% |
| 2 | $18.56 | 12,500 | $232K | 50.0% |
| Total | $18.56 avg | 25,000 | $464K | 100% |
| Filing → |
| CHRS | SELL | 2019-11-22 | $14.8M | — | Filing → |
| CHRS | SELL | 2019-05-31 | $1.3M | — | Filing → |
| CHRS | SELL | 2018-05-17 | $682K | — | Filing → |